OnKure Therapeutics, Inc. (OKUR)
NASDAQ: OKUR · Real-Time Price · USD
2.410
+0.110 (4.78%)
At close: Oct 9, 2026, 4:00 PM EDT
2.430
+0.020 (0.83%)
After-hours: Oct 9, 2026, 6:09 PM EDT
OnKure Therapeutics Market Cap
OnKure Therapeutics has a market cap or net worth of $97.6 million as of October 9, 2026. It is the 25,618th most valuable company in the world and the 4,145th biggest in the United States. Its market cap has increased by 137.28% in one year.
Market Cap
97.60M
Enterprise Value
-77.86M
1-Year Change
137.28%
Global Rank
Country Rank
#4,145 United States
Category
ChartMarket Cap Chart
Since October 7, 2024, OnKure Therapeutics's market cap has decreased from $248.78M to $97.60M, a decrease of -60.77%. That is a compound annual growth rate of -37.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 97.60M | 148.40% |
| Dec 31, 2025 | 39.29M | -65.75% |
| Dec 31, 2024 | 114.72M | -53.89% |
| Oct 7, 2024 | 248.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Conexeu Sciences | 102.67M |
| Anixa Biosciences | 102.55M |
| Tevogen | 102.13M |
| PolyPid | 100.54M |
| Cellectis | 99.91M |
| Biomea Fusion | 95.68M |
| Atara Biotherapeutics | 94.05M |
| Rallybio | 89.91M |